** Nehru Planetarium director is dead

Director of the Nehru Planetarium N. Rathnasree passed away on Sunday, the Culture Ministry said on Tuesday.

In a statement on Twitter and Facebook, the Ministry, under which the Nehru Memorial Museum and Library (NMML) and planetarium function, said: “Extremely saddened to learn about the unfortunate demise of Dr. N. Rathnasree, Director of Nehru Planetarium under @_NMML_ passed away on Sunday

** India-born Ivy League alumni and students come together to raise funds to fight COVID-19

Make a donation to a cause fighting COVID-19 and get a one-on-one counselling session with industry professionals and alumni of top institutions across the world

Rather than feel helpless when the second wave of COVID-19 hit the country, US-based Princeton alumni Shreyas Lakhtakia and Julu Beth Katticaran turned “the negative emotion of being away from India into a positive one by offering help”. This eventually led to the formation of Students Fight COVID (studentsfightcovid.in), a fund-raiser for COVID-hit in India.

** Sukh-Dukh, a helpline by Pallium India, provides counselling in eight Indian languages

The Kerala-based NGO provides grief counselling for those who have lost a family member due to COVID-19 through the helpline

The calls for help from all over India are from those trying to come to terms with the loss of a family member due to COVID-19. And Pallium India, a non-Governmental organisation headquartered in Thiruvananthapuram, is helping them overcome the numbing grief with the help of Sukh-Dukh, a helpline that provides counselling in eight Indian languages.

** Snapdeal creates platform to connect patients with plasma donors

E-commerce firm Snapdeal on Monday launched a new platform which can be used to connect COVID-19 patients with potential plasma donors.

The platform, called ‘Sanjeevani’, is accessible via website as well as mobile application. Patients and donors can register themselves with their mobile numbers/email ids and provide relevant information like blood group, location, age and donor recovery date.

** The Univer-cell Alchemist: Dr Subhadra Dravida’s breakthrough research on novel stem cell treatment for Covid patients

Bio-entrepreneur Dr Subhadra Dravida is inspired by Paulo Coelho.

Her favourite line is from The Alchemist “When you seek something, all the Universe conspires in helping you to achieve it.” Says the scientist and owner of healthcare startup Transcell Oncologics,

“Since the news of the virus erupted in March 2020, I had been thinking on these lines. And in three months it happened. If everything goes well, our solution will actually get implemented in a month or two in India.”

The Universe did step in and Dravida is the new medical star whose breakthrough research on a novel stem cell treatment holds promise for Covid patients.  

Hyderabad

** Drug 2-DG will work wonders in fighting coronavirus, says Ex-CCMB director Rakesh Mishra

Former Director of Centre for Cellular and Molecular Biology (CCMB), Dr Rakesh Mishra, said that 2-deoxy-D-glucose (2-DG) drug would do wonders in fighting against mild and severe Covid-19 cases.

This anti Covid-19 drug developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a Defence Research and Development Organisation along with Dr Reddy’s Laboratories, with the help of CCMB has been approved by the Drug Controller General of India.

** Imports of oxygen concentrators, supplies from China surge

Most of the supplies coming in from China have been imported by private Indian companies on a commercial basis.

Chinese companies manufacturing oxygen concentrators and other medical supplies are reporting a record surge in orders for April and May from Indian companies amid the current wave of COVID-19 cases and shortages in supplies.

Since April, orders for at least 40,000 oxygen concentrators have been placed by Indian companies, of which 21,000 have so far been delivered, along with more than 5,000 ventilators, 21 million face masks and 3,800 tons of medicines, according to official Chinese customs figures

** Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment

Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients, the Natco Pharma said

Drugmaker Natco Pharma has received emergency use approval for Baricitinib tablets, 1 mg, 2 mg and 4 mg strengths, from Central Drugs Standard Control Organisation (CDSCO) in India. 

Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19 positive patients, a release from Natco on the approval said.